Literature DB >> 30427525

Nematode resistance to five anthelmintic classes in naturally infected sheep herds in Northeastern Brazil.

Francisca Flávia da Silva1, Hermano Manoel Francisco Figueiredo Bezerra2, Thais Ferreira Feitosa2, Vinícius Longo Ribeiro Vilela2.   

Abstract

This study aimed to evaluate the occurrence of nematode resistance to anthelmintics on sheep herds from the semi-arid region of Paraíba, Northeastern Brazil. Fecal Egg Count Reduction Test (FECRT) was carried out on 20 properties. In each herd, 30 animals were divided into five groups containing six animals each: group I, treated with albendazole 10%, 4 mg/kg; group II, ivermectin 0.08%, 0.2 mg/kg; group III, closantel 10%, 10 mg/kg; group IV, levamisole hydrochloride 5%, 5 mg/kg; and group V, monepantel 2.5%, 2.5 mg/kg. All treatments were administered orally as a single dose. Fecal samples were collected on days zero and 10 after treatment, to perform FECRT and coprocultures. Multiresistance was observed in all the properties; 95% had high resistance to albendazole, 85% to ivermectin, 80% to closantel, 40% to levamisole, and 45% to monepantel. On property 15, where monepantel was ineffective, a second FECRT for this anthelmintic was carried out 4 months after the first, resulting in 75% efficacy. Immediately after the FECRT result, two ewes were euthanized and necropsied, and Haemonchus contortus, Trichostrongylus axei, Trichostrongylus colubriformis, Oesophagostomum columbianum, and Trichuris ovis were recovered. It was concluded that the resistance of sheep gastrointestinal nematodes to antthelmintic, including monepantel, is high.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30427525     DOI: 10.1590/S1984-296120180071

Source DB:  PubMed          Journal:  Rev Bras Parasitol Vet        ISSN: 0103-846X


  1 in total

Review 1.  Natural Products Are a Promising Source for Anthelmintic Drug Discovery.

Authors:  K L T Dilrukshi Jayawardene; Enzo A Palombo; Peter R Boag
Journal:  Biomolecules       Date:  2021-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.